Joshua Smiley
President chez ZAI LAB LIMITED
Fortune : 52 664 $ au 30/04/2024
Profil
Actuellement, Joshua L. Smiley est trésorier, directeur et vice-président de CoLucid Pharmaceuticals, Inc. M. Smiley est également membre du conseil d'administration de l'université de Butler et de la Fondation Eskenazi Health. Dans sa carrière antérieure, il a été directeur financier et vice-président senior chez Eli Lilly & Co. et directeur financier, contrôleur et vice-président senior des finances chez Lilly Research Laboratories (une filiale d'Eli Lilly & Co.). Joshua L. Smiley a obtenu un diplôme de premier cycle à l'université de Harvard.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZAI LAB LTD.
0,00% | 13/05/2024 | 31 684 ( 0,00% ) | 52 664 $ | 30/04/2024 |
Postes actifs de Joshua Smiley
| Sociétés | Poste | Début |
|---|---|---|
| ZAI LAB LIMITED | President | - |
| Butler University | Directeur/Membre du Conseil | - |
| Eskenazi Health Foundation | Directeur/Membre du Conseil | - |
Unseen Capital LLC
 Unseen Capital LLC Investment ManagersFinance Unseen Capital LLC (Unseen Capital) is a venture capital firm founded in 2020 by Warnell Kayode Owens. The firm is headquartered in New York. | Consultant / Advisor | - |
Anciens postes connus de Joshua Smiley
| Sociétés | Poste | Fin |
|---|---|---|
| ELI LILLY AND COMPANY | Directeur Financier/CFO | 09/02/2021 |
| ELANCO ANIMAL HEALTH INCORPORATED | Directeur/Membre du Conseil | 11/03/2019 |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Directeur Financier/CFO | 01/01/2015 |
| COLUCID PHARMACEUTICALS INC | Directeur/Membre du Conseil | - |
Gilead Connecticut, Inc.
 Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Directeur/Membre du Conseil | - |
Formation de Joshua Smiley
| Harvard University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| ELANCO ANIMAL HEALTH INCORPORATED | Health Technology |
| ZAI LAB LIMITED | Health Technology |
| Entreprise privées | 5 |
|---|---|
Gilead Connecticut, Inc.
Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Health Technology |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Commercial Services |
CoLucid Pharmaceuticals, Inc.
 CoLucid Pharmaceuticals, Inc. BiotechnologyHealth Technology CoLucid Pharmaceuticals, Inc. engaged in the development of therapeutics for neurological disorders. Its products included Lasmiditan, a neurally acting anti-migraine agent that is designed to delivered efficacy in migraine without the vasoconstrictor activity associated with previous generations of migraine therapies and a Conjugated Stigmines platform that has generated a series of preclinical candidates for the chronic pain, Alzheimer's disease and psychiatric disorders. The company was founded by James F. White and Arthur M. Pappas in 2005 and was headquartered in Cambridge, MA. | Health Technology |
| Eskenazi Health Foundation | |
Unseen Capital LLC
Unseen Capital LLC Investment ManagersFinance Unseen Capital LLC (Unseen Capital) is a venture capital firm founded in 2020 by Warnell Kayode Owens. The firm is headquartered in New York. | Finance |
